NURIX THERAPEUTICS INC (NRIX) Stock Earnings & Estimates
NASDAQ:NRIX - US67080M1036 - Common Stock
9.345 USD
-0.06 (-0.69%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 38.63M 29.85% | 76.987M 99.29% | 54.549M -29.15% | 95.239M 74.59% | 62.715M -34.15% | 86.54M 37.99% | 170.79M 97.35% | 342.43M 100.50% | 545.27M 59.24% | 761.56M 39.67% | 1.107B 45.36% | |
| EBITDA YoY % growth | -178.52M -55.10% | -141.409M 20.79% | -196.599M -39.03% | -237.982M -21.05% | -304.567M -27.98% | -306.182M -0.53% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -183.87M -55.97% | -155.063M 15.67% | -213.027M -37.38% | -271.985M -27.68% | -339.067M -24.66% | -359.685M -6.08% | -339.774M 5.54% | -226.211M 33.42% | -29.76M 86.84% | 164.42M 652.48% | 544.99M 231.46% | |
| Operating Margin | -475.98% | -201.41% | -390.52% | -285.58% | -540.65% | -415.63% | -198.94% | -66.06% | -5.46% | 21.59% | 49.23% | |
| EPS YoY % growth | -3.73 -36.63% | -2.65 28.95% | -2.89 -9.06% | -3.04 -5.04% | -3.70 -21.91% | -3.53 4.59% | -2.98 15.72% | -1.75 41.17% | 0.10 105.74% | 2.31 2,198.17% | 4.74 104.94% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.86 -28.06% | -0.92 -22.24% | -0.92 -37.01% | -0.93 -78.89% | -0.98 -14.13% | -0.93 -1.47% |
| Revenue Q2Q % growth | 16.004M 27.14% | 14.301M 7.66% | 17.444M -5.47% | 18.746M -57.45% | 17.254M 7.81% | 24.572M 71.82% |
| EBITDA Q2Q % growth | -87.689M -106.40% | -97.165M -101.47% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -79.755M -46.04% | -83.56M -29.24% | -83.26M -32.44% | -84.258M -74.37% | -88.414M -10.86% | -90.696M -8.54% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.52 26.76% | -0.74 | 0.22 | 30.11% |
| Q1 2025 Q2Q % growth | -0.67 11.84% | -0.78 | 0.11 | 13.97% |
| Q4 2024 Q2Q % growth | -0.75 2.60% | -0.69 | -0.06 | -8.65% |
| Q3 2024 Q2Q % growth | -0.67 1.47% | -0.72 | 0.05 | 7.58% |
| Q2 2024 Q2Q % growth | -0.71 -57.78% | -0.65 | -0.06 | -9.62% |
| Q1 2024 Q2Q % growth | -0.76 -1.33% | -0.82 | 0.06 | 7.10% |
| Q4 2023 Q2Q % growth | -0.77 11.49% | -0.58 | -0.19 | -32.44% |
| Q3 2023 Q2Q % growth | -0.68 24.44% | -0.77 | 0.09 | 11.80% |
| Q2 2023 Q2Q % growth | -0.45 55.45% | -0.57 | 0.12 | 21.22% |
| Q1 2023 Q2Q % growth | -0.75 21.05% | -0.89 | 0.14 | 15.29% |
| Q4 2022 Q2Q % growth | -0.87 -2.35% | -0.80 | -0.07 | -8.12% |
| Q3 2022 Q2Q % growth | -0.90 -38.46% | -1.00 | 0.10 | 9.55% |
| Q2 2022 Q2Q % growth | -1.01 -68.33% | -1.01 | 0.00 | -0.40% |
| Q1 2022 Q2Q % growth | -0.95 -50.79% | -0.89 | -0.06 | -6.36% |
| Q4 2021 Q2Q % growth | -0.85 -66.67% | -0.71 | -0.14 | -20.12% |
| Q3 2021 Q2Q % growth | -0.65 -10.17% | -0.64 | -0.01 | -0.92% |
| Q2 2021 Q2Q % growth | -0.60 | -0.55 | -0.05 | -8.26% |
| Q1 2021 Q2Q % growth | -0.63 | -0.47 | -0.16 | -34.86% |
| Q4 2020 Q2Q % growth | -0.51 | -0.55 | 0.04 | 7.06% |
| Q3 2020 Q2Q % growth | -0.59 | -0.42 | -0.17 | -40.23% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 44.056M 264.34% | 17.349M | 26.707M | 153.94% |
| Q1 2025 Q2Q % growth | 18.453M 11.26% | 12.968M | 5.485M | 42.30% |
| Q4 2024 Q2Q % growth | 13.284M -12.37% | 13.116M | 168K | 1.28% |
| Q3 2024 Q2Q % growth | 12.588M -31.84% | 12.284M | 304K | 2.47% |
| Q2 2024 Q2Q % growth | 12.092M -60.58% | 22.547M | -10.455M | -46.37% |
| Q1 2024 Q2Q % growth | 16.585M 30.69% | 16.977M | -392K | -2.31% |
| Q4 2023 Q2Q % growth | 15.159M 123.58% | 22.707M | -7.548M | -33.24% |
| Q3 2023 Q2Q % growth | 18.467M 71.15% | 17.572M | 895K | 5.09% |
| Q2 2023 Q2Q % growth | 30.676M 168.38% | 26.74M | 3.936M | 14.72% |
| Q1 2023 Q2Q % growth | 12.69M 31.91% | 11.088M | 1.602M | 14.45% |
| Q4 2022 Q2Q % growth | 6.78M -8.38% | 17.515M | -10.735M | -61.29% |
| Q3 2022 Q2Q % growth | 10.79M 5.27% | 12.325M | -1.535M | -12.45% |
| Q2 2022 Q2Q % growth | 11.43M 61.21% | 10.71M | 720K | 6.72% |
| Q1 2022 Q2Q % growth | 9.62M 92.02% | 9.459M | 161K | 1.70% |
| Q4 2021 Q2Q % growth | 7.4M 10.61% | 13.459M | -6.059M | -45.02% |
| Q3 2021 Q2Q % growth | 10.25M 150.61% | 8.715M | 1.535M | 17.61% |
| Q2 2021 Q2Q % growth | 7.09M 69.62% | 8.391M | -1.301M | -15.50% |
| Q1 2021 Q2Q % growth | 5.01M 75.17% | 8.099M | -3.089M | -38.14% |
| Q4 2020 Q2Q % growth | 6.69M 259.68% | 4.024M | 2.666M | 66.25% |
| Q3 2020 Q2Q % growth | 4.09M -61.34% | 6.464M | -2.374M | -36.73% |
| Q2 2020 Q2Q % growth | 4.18M -55.72% | % | ||
| Q1 2020 Q2Q % growth | 2.86M -69.01% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.44% | -4.76% | -1.25% | 1.8% |
| Revenue | -0.58% | 11.72% | 29.45% | 51.25% |